At least one patient has received a virus designed by AI, according to the company behind it, but nobody outside that company can yet say whether it worked.
Radical Numerics, an AI bioscience startup, posted a paper on its own website describing the treatment. Its model, Omnii-1, designed a phage (a virus that attacks bacteria, not human cells) to target that patient's particular bacterial infection. The company says it is the first treatment of its kind.
The "first" is a narrow one. Phage therapy already exists as an experimental treatment: doctors give a person with a serious bacterial infection viruses meant to kill the bacteria causing it. What is new, by the company's account, is that an AI model designed this specific phage for this specific infection, and that it then went into a person.
The gaps are large. The paper was not peer-reviewed or published in a scientific journal, so it carries about the same weight as a company blog post. The trial is ongoing, and Radical Numerics will not share details about the patient or the doctors, citing confidentiality agreements. CEO Eric Nguyen said the team plans to release more once the patient consents.
That leaves a claim about a pipeline, not a therapy. If the account holds, it shows an AI-designed virus can be made and administered. It says nothing yet about whether the treatment is safe or whether it cleared the infection, and a single case could not settle either question anyway.
The answer will also arrive slowly. Phage therapy can run from a couple of days to a few weeks, and doctors then monitor the patient for months to confirm the infection is gone and will not return. The more telling moment may come after that: whether the company submits its data to a journal or posts another update on its own site.